Tyra Biosciences Inc (NASDAQ:TYRA) shares, rose in value on Thursday, April 16, with the stock price up by 3.60% to the previous day’s close as strong demand from buyers drove the stock to $8.92.
Actively observing the price movement in the last trading, the stock closed the session at $8.61, falling within a range of $8.3 and $8.99. The value of beta (5-year monthly) was 1.187. Referring to stock’s 52-week performance, its high was $29.60, and the low was $6.42. On the whole, TYRA has fluctuated by -20.07% over the past month.
With the market capitalization of Tyra Biosciences Inc currently standing at about $473.56 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-26.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TYRA’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of TYRA currently trading nearly 1.07% and -15.73% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 45.97, while the 7-day volatility ratio is showing 6.48% which for the 30-day chart, stands at 8.60%. Furthermore, Tyra Biosciences Inc (TYRA)’s beta value is 1.19, and its average true range (ATR) is 0.75.
A comparison of Tyra Biosciences Inc (TYRA) with its peers suggests the former has fared considerably weaker in the market. TYRA showed an intraday change of 3.60% in last session, and over the past year, it shrunk by -39.17%%.
Data on historical trading for Tyra Biosciences Inc (NASDAQ:TYRA) indicates that the trading volumes over the past 10 days have averaged 0.4 and over the past 3 months, they’ve averaged 309.70K. According to company’s latest data on outstanding shares, there are 50.75 million shares outstanding.
Nearly 39.40% of Tyra Biosciences Inc’s shares belong to company insiders and institutional investors own 62.61% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.75 million shares as on 2025-03-31, resulting in a short ratio of 11.05. According to the data, the short interest in Tyra Biosciences Inc (TYRA) stood at 1263.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 4.08 million. The stock has fallen by -35.83% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TYRA stock heading into the next quarter.
